Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms (2021)
- Authors:
- USP affiliated authors: CACEMIRO, MAIRA DA COSTA - FCFRP ; FRANTZ, FABIANI GAI - FCFRP ; COVAS, DIMAS TADEU - FMRP ; PONTES, LORENA LÔBO DE FIGUEIREDO - FMRP ; FARIAS, KELEN CRISTINA RIBEIRO MALMEGRIM DE - FCFRP ; CASTRO, FABÍOLA ATTIÉ DE - FCFRP ; RODRIGUES, MARIA CAROLINA DE OLIVEIRA - FMRP ; COMINAL, JUÇARA GASTALDI - FCFRP ; PEREIRA, ILLY ENNE GOMES - FCFRP
- Unidades: FCFRP; FMRP
- DOI: 10.3389/fonc.2021.665037
- Subjects: NEOVASCULARIZAÇÃO PATOLÓGICA; MEDULA ÓSSEA; CITOCINAS; INFLAMAÇÃO; NEOPLASIAS
- Keywords: Angiogenesis; Bone marrow niche; Cytokines; Inflammation; Myeloproliferative neoplasms; Soluble mediators
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Oncology
- ISSN: 2234-943X
- Volume/Número/Paginação/Ano: v. 11, art. 665037, p. 1-12 , 2021
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
COMINAL, Juçara Gastaldi et al. Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Frontiers in Oncology, v. 11, p. 1-12 , 2021Tradução . . Disponível em: https://doi.org/10.3389/fonc.2021.665037. Acesso em: 01 abr. 2026. -
APA
Cominal, J. G., Cacemiro, M. da C., Berzoti-Coelho, M. G., Pereira, I. E. G., Frantz, F. G., Souto, E. X., et al. (2021). Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Frontiers in Oncology, 11, 1-12 . doi:10.3389/fonc.2021.665037 -
NLM
Cominal JG, Cacemiro M da C, Berzoti-Coelho MG, Pereira IEG, Frantz FG, Souto EX, Covas DT, Figueiredo-Pontes LL de, Oliveira MC, Malmegrim KCR, Castro FA de. Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms [Internet]. Frontiers in Oncology. 2021 ; 11 1-12 .[citado 2026 abr. 01 ] Available from: https://doi.org/10.3389/fonc.2021.665037 -
Vancouver
Cominal JG, Cacemiro M da C, Berzoti-Coelho MG, Pereira IEG, Frantz FG, Souto EX, Covas DT, Figueiredo-Pontes LL de, Oliveira MC, Malmegrim KCR, Castro FA de. Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms [Internet]. Frontiers in Oncology. 2021 ; 11 1-12 .[citado 2026 abr. 01 ] Available from: https://doi.org/10.3389/fonc.2021.665037 - Emerging role of mesenchymal stromal cell-derived extracellular vesicles in pathogenesis of haematological malignancies
- Arachidonic acid (aa)-derived lipid mediators are increased in the bone marrow plasma from polycythemia vera and essential thrombocythemia patients
- Deregulation of bone marrow eicosanoids in essential thrombocythemia and primary myelofibrosis patients
- Type I and II interferon are associated with high expression of the hippo pathway family members
- Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?
- New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement
- Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II
- Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand?
- Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?
- Lower Insulin-Dose Adjusted A1c (IDAA1c) is associated with less complications in individuals with type 1 diabetes treated with hematopoetic stem-cell transplantation and conventional therapy
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
